Obermatt
See Similar Stocks →

Aura Biosciences

NMQ:AURA · US05153U1079
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book5
Dividend Yield—
Revenue Growth—
Profit Growth55
Capital Growth58
TSR 52w19
Leverage39
Liquidity75
Refinancing45
Combined—
Analyst Opinions74
Pro Holdings43
Opinion Changes50
Market Pulse78

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2009
Employees114
Websiteaurabiosciences.com
ISINUS05153U1079
Last UpdateApr 2, 2026
Index & Theme
UrologyImmunologyOphthalmologyOncologyBiotechnologyHealth CarePharmaceutical

Description

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors designed to preserve organ function. The company’s lead candidate, bel-sar, is in late-stage clinical development for the treatment of…

Similar Stocks

The companies this stock is ranked against.

Compare Aura Biosciences with its peers
Legend Biotech
NSQ:LEGN
30
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Celcuity
NAQ:CELC
96
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Larimar Therapeutics
NMQ:LRMR
26
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Immuneering
NMQ:IMRX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Pyxis Oncology
NSQ:PYXS
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Protara Therapeutics
NMQ:TARA
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →